THE COGNIGENICS APPROACH
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a revolutionary genetic technology that allows for precise editing of DNA. It functions like molecular scissors, cutting DNA at a specific location and allowing researchers to add, remove, or replace specific sections of genetic code. This technology has immense potential for treating a wide range of genetic diseases. By using CRISPR to target and modulate specific neuronal receptors known to be associated with mental health disorders, we can vastly improve overall cognitive health and wellbeing and potentially eradicate these conditions.
THE COGNIGENICS BREAKTHROUGH INNOVATION
We have successfully engineered a way to noninvasively overcome one of the primary challenges in transporting CRISPR’s molecular cargo through the blood brain barrier. Our intranasal delivery is an important development because other genetic treatments for neurodegenerative diseases typically inject the cargo directly into the brain through a hole drilled through the skull, or the cargo is delivered intravenously.
The neurotransmitters we aim to modulate, which are implicated in multiple mental health disorders, and located in specific areas of the brain, have previously been difficult or impossible to target noninvasively. Our patent-pending technology solves this problem.